MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 14, 2015

Primary Completion Date

April 25, 2017

Study Completion Date

May 17, 2018

Conditions
Anxiety
Interventions
DRUG

Midomafetamine HCl

Two sessions of MDMA-assisted therapy lasting six to eight hours, scheduled two to four weeks apart.

DRUG

Placebo

Two sessions of placebo with therapy lasting six to eight hours, scheduled two to four weeks apart.

BEHAVIORAL

Therapy

Manualized therapy

Trial Locations (1)

94960

Offices of Philip Wolfson MD, San Anselmo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lykos Therapeutics

INDUSTRY